Journey Medical Corp (DERM)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch DERM
See up to 3 months of DERM. The 7-day demo opens the 1M and 3M ranges and puts DERM on your watchlist.
Start 7-day demoLatest DERM insider trades
About Journey Medical Corp (DERM)
Journey Medical Corp is an SEC registrant, filing under CIK 0001867066, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
DERM Form 4 activity by transaction type, last 90 days
No Form 4 activity for DERM in the last 90 days.
DERM insider transactions (Form 4)
2722 Form 4 filings on record, the earliest from Jun 25, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Michael Cooper Pearce - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Lindsay A. Md Rosenwald - Director | Grant or award | Common Stock, $0.0001 par value | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Ramsey Alloush - Officer | Grant or award | Common Stock, $0.0001 par value | 46,863 footnote F1 | $0.00 | - | |
| Ramsey Alloush - Officer | Grant or award | Stock Option (Right to Buy) | 62,795 | $0.00 | - | |
| ||||||
 Joseph Benesch - Officer | Grant or award | Common Stock, $0.0001 par value | 28,907 footnote F1 | $0.00 | - | |
| Joseph Benesch - Officer | Grant or award | Stock Option (Right to Buy) | 41,860 | $0.00 | - | |
| ||||||
| Claude Maraoui - Officer | Grant or award | Common Stock, $0.0001 par value | 49,277 footnote F1 | $0.00 | - | |
| Claude Maraoui - Officer | Grant or award | Stock Option (Right to Buy) | 82,915 | $0.00 | - | |
| ||||||
| Claude Maraoui - Officer | Option exercise | Common Stock, $0.0001 par value | 1,250,000 | $0.07 | $81K | |
| Claude Maraoui - Officer | Tax withholding / forfeiture | Common Stock, $0.0001 par value | 10,877 | $7.47 | $81K | |
| Claude Maraoui - Officer | Option exercise | Stock Option (Right to Buy) | 1,250,000 | $0.00 | - | |
| Lindsay A. Md Rosenwald - Director | Grant or award | Common Stock, $0.0001 par value | 50,000 | $0.00 | - | |
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Michael Cooper Pearce - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 20,000 | $0.00 | - | |
| Lindsay A. Md Rosenwald - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Justin Adam Smith - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Miranda Jayne Toledano - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Michael Cooper Pearce - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
| Neil Herskowitz - Director | Grant or award | Common Stock, $0.0001 par value | 7,173 | $0.00 | - | |
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Item 8.01, 9.01
DERM insider trading FAQ
What is the latest insider trade for DERM?
Journey Medical Corp (DERM) has filed no insider reports in the last 90 days. The most recent on record is dated 2 July 2026. The full record for DERM runs to 22 Form 4 filings, the earliest from 25 June 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DERM stock?
No insider purchases of DERM were filed in the last 90 days.
How many insiders are selling DERM stock?
No insider sales of DERM were filed in the last 90 days.
Where can I see DERM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DERM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Miranda Jayne Toledano view on EDGAR
- - Justin Adam Smith view on EDGAR
- - Neil Herskowitz view on EDGAR
- - Miranda Jayne Toledano view on EDGAR
- - Justin Adam Smith view on EDGAR
- - Neil Herskowitz view on EDGAR
- - Michael Cooper Pearce view on EDGAR
- - Lindsay A. Md Rosenwald view on EDGAR
- - Ramsey Alloush view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DERM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DERM with a 7-day demo
- DERM on your watchlist
- Every DERM Form 4 filing on record
- Up to 3 months of DERM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
